154 related articles for article (PubMed ID: 17337777)
1. Dendritic cell immunotherapy for autoimmune diabetes.
Feili-Hariri M; Flores RR; Vasquez AC; Morel PA
Immunol Res; 2006; 36(1-3):167-73. PubMed ID: 17337777
[TBL] [Abstract][Full Text] [Related]
2. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
[TBL] [Abstract][Full Text] [Related]
3. Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse.
Kadri N; Potiron N; Ouary M; Jegou D; Gouin E; Bach JM; Lieubeau B
Immunol Lett; 2007 Feb; 108(2):129-36. PubMed ID: 17196260
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells expressing BTLA induces CD8+ T cell tolerance and attenuates the severity of diabetes.
Li S; Zhang M; Xiang F; Zhao J; Jiang C; Zhu J
Vaccine; 2011 Oct; 29(44):7747-51. PubMed ID: 21827810
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells and the maintenance of self-tolerance.
Morel PA; Turner MS
Immunol Res; 2011 Aug; 50(2-3):124-9. PubMed ID: 21717078
[TBL] [Abstract][Full Text] [Related]
6. Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice.
Feili-Hariri M; Falkner DH; Morel PA
Eur J Immunol; 2002 Jul; 32(7):2021-30. PubMed ID: 12115623
[TBL] [Abstract][Full Text] [Related]
7. Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells.
Krueger T; Wohlrab U; Klucken M; Schott M; Seissler J
Diabetologia; 2003 Oct; 46(10):1357-65. PubMed ID: 12928772
[TBL] [Abstract][Full Text] [Related]
8. Marked dendritic cell-T cell cluster formation in the pancreatic lymph node of the non-obese diabetic mouse.
Clare-Salzler M; Mullen Y
Immunology; 1992 Jul; 76(3):478-84. PubMed ID: 1356097
[TBL] [Abstract][Full Text] [Related]
9. Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development.
O'Keeffe M; Brodnicki TC; Fancke B; Vremec D; Morahan G; Maraskovsky E; Steptoe R; Harrison LC; Shortman K
Int Immunol; 2005 Mar; 17(3):307-14. PubMed ID: 15684037
[TBL] [Abstract][Full Text] [Related]
10. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.
Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M
J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441
[TBL] [Abstract][Full Text] [Related]
11. Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells.
Haase C; Yu L; Eisenbarth G; Markholst H
Clin Exp Immunol; 2010 Jun; 160(3):331-9. PubMed ID: 20180832
[TBL] [Abstract][Full Text] [Related]
12. Defects in the differentiation and function of bone marrow-derived dendritic cells in non-obese diabetic mice.
Lee M; Kim AY; Kang Y
J Korean Med Sci; 2000 Apr; 15(2):217-23. PubMed ID: 10803701
[TBL] [Abstract][Full Text] [Related]
13. Splenic dendritic cells from the non-obese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells?
Radosevic K; Casteels KM; Mathieu C; Van Ewijk W; Drexhage HA; Leenen PJ
J Autoimmun; 1999 Dec; 13(4):373-82. PubMed ID: 10585753
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
15. IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice.
Tai N; Yasuda H; Xiang Y; Zhang L; Rodriguez-Pinto D; Yokono K; Sherwin R; Wong FS; Nagata M; Wen L
Clin Immunol; 2011 Jun; 139(3):336-49. PubMed ID: 21458378
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
Li AF; Hough J; Henderson D; Escher A
Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859
[TBL] [Abstract][Full Text] [Related]
17. The immunotherapeutic potential of dendritic cells in type 1 diabetes.
Mukherjee G; Dilorenzo TP
Clin Exp Immunol; 2010 Aug; 161(2):197-207. PubMed ID: 20491789
[TBL] [Abstract][Full Text] [Related]
18. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice.
Boudaly S; Morin J; Berthier R; Marche P; Boitard C
Eur Cytokine Netw; 2002; 13(1):29-37. PubMed ID: 11956018
[TBL] [Abstract][Full Text] [Related]
19. Targeting B-cells mitigates autoimmune diabetes in NOD mice: what is plan B?
Smith SH; Tedder TF
Diabetes; 2009 Jul; 58(7):1479-81. PubMed ID: 19564459
[No Abstract] [Full Text] [Related]
20. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
